Erratum: MiR145 Targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL6-mediated paracrine effects in head and neck cancer (Cancer Research (2013) 73 (3425-3440))

C. C. Yu; L. L. Tsai; M. L. Wang; C. C. Yu; W. L. Lo; Y. C. Chang

doi:10.1158/0008-5472.CAN-15-1351

Erratum: MiR145 Targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL6-mediated paracrine effects in head and neck cancer (Cancer Research (2013) 73 (3425-3440))

C. C. Yu, L. L. Tsai, M. L. Wang, C. C. Yu, W. L. Lo, Y. C. Chang

牙醫學系

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

原文	英語
頁（從 - 到）	2761
頁數	1
期刊	Cancer Research
卷	75
發行號	13
DOIs	https://doi.org/10.1158/0008-5472.CAN-15-1351
出版狀態	已發佈 - 7月 1 2015

ASJC Scopus subject areas

腫瘤科
癌症研究

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1158/0008-5472.CAN-15-1351

其它文件與鏈接

引用此

@article{5d16fd33769843d484ae1174e326d456,

title = "Erratum: MiR145 Targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL6-mediated paracrine effects in head and neck cancer (Cancer Research (2013) 73 (3425-3440))",

author = "Yu, {C. C.} and Tsai, {L. L.} and Wang, {M. L.} and Yu, {C. C.} and Lo, {W. L.} and Chang, {Y. C.}",

year = "2015",

month = jul,

day = "1",

doi = "10.1158/0008-5472.CAN-15-1351",

language = "English",

volume = "75",

pages = "2761",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "13",

}

TY - JOUR

T1 - Erratum

T2 - MiR145 Targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL6-mediated paracrine effects in head and neck cancer (Cancer Research (2013) 73 (3425-3440))

AU - Yu, C. C.

AU - Tsai, L. L.

AU - Wang, M. L.

AU - Yu, C. C.

AU - Lo, W. L.

AU - Chang, Y. C.

PY - 2015/7/1

Y1 - 2015/7/1

UR - http://www.scopus.com/inward/record.url?scp=84942906665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942906665&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-15-1351

DO - 10.1158/0008-5472.CAN-15-1351

M3 - Comment/debate

C2 - 26081811

AN - SCOPUS:84942906665

SN - 0008-5472

VL - 75

SP - 2761

JO - Cancer Research

JF - Cancer Research

IS - 13

ER -